Does the media favor OM or TLSI?

In the previous week, TriSalus Life Sciences had 1 more articles in the media than Outset Medical. MarketBeat recorded 2 mentions for TriSalus Life Sciences and 1 mentions for Outset Medical. TriSalus Life Sciences' average media sentiment score of 0.77 beat Outset Medical's score of 0.76 indicating that TriSalus Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TriSalus Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to RCEL or OM?

In the previous week, Avita Medical and Avita Medical both had 1 articles in the media. Avita Medical's average media sentiment score of 1.00 beat Outset Medical's score of 0.76 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Outset Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is OM or CV more profitable?

Outset Medical has a net margin of -63.06% compared to CapsoVision's net margin of -214.74%. Outset Medical's return on equity of -61.67% beat CapsoVision's return on equity. Company Net Margins Return on Equity Return on Assets Outset Medical -63.06% -61.67% -28.25% CapsoVision -214.74% -177.85% -135.07%

Does the media prefer OM or CV?

In the previous week, CapsoVision had 4 more articles in the media than Outset Medical. MarketBeat recorded 5 mentions for CapsoVision and 1 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.76 beat CapsoVision's score of 0.60 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CapsoVision 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer OM or TMCI?

In the previous week, Outset Medical and Outset Medical both had 1 articles in the media. Treace Medical Concepts' average media sentiment score of 1.34 beat Outset Medical's score of 0.76 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer OM or PROF?

In the previous week, Profound Medical had 3 more articles in the media than Outset Medical. MarketBeat recorded 4 mentions for Profound Medical and 1 mentions for Outset Medical. Profound Medical's average media sentiment score of 0.83 beat Outset Medical's score of 0.76 indicating that Profound Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Profound Medical 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Outset Medical (OM) Competitors

$3.67 +0.03 (+0.82%)

Closing price 09/2/2026 04:00 PM Eastern

Extended Trading

$3.70 +0.04 (+0.95%)

As of 09/2/2026 07:30 PM Eastern

Compare

OM vs. TLSI, RCEL, CV, TMCI, and PROF

Should you buy Outset Medical stock or one of its competitors? Outset Medical's main competitors and comparable companies include TriSalus Life Sciences (TLSI), Avita Medical (RCEL), CapsoVision (CV), Treace Medical Concepts (TMCI), and Profound Medical (PROF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Outset Medical compare to TriSalus Life Sciences?

Outset Medical (NASDAQ:OM) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

2.6% of TriSalus Life Sciences shares are held by institutional investors. 2.5% of Outset Medical shares are held by insiders. Comparatively, 16.3% of TriSalus Life Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

TriSalus Life Sciences has a net margin of -62.59% compared to Outset Medical's net margin of -63.06%. TriSalus Life Sciences' return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
TriSalus Life Sciences	-62.59%	N/A	-64.47%

TriSalus Life Sciences has lower revenue, but higher earnings than Outset Medical. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.58	-$81.65M	-$4.09	N/A
TriSalus Life Sciences	$45.08M	7.02	-$39.23M	-$1.30	N/A

In the previous week, TriSalus Life Sciences had 1 more articles in the media than Outset Medical. MarketBeat recorded 2 mentions for TriSalus Life Sciences and 1 mentions for Outset Medical. TriSalus Life Sciences' average media sentiment score of 0.77 beat Outset Medical's score of 0.76 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TriSalus Life Sciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Outset Medical currently has a consensus price target of $10.00, suggesting a potential upside of 172.48%. TriSalus Life Sciences has a consensus price target of $7.50, suggesting a potential upside of 45.91%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts plainly believe Outset Medical is more favorable than TriSalus Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Outset Medical has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market.

Summary

TriSalus Life Sciences beats Outset Medical on 9 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Outset Medical (NASDAQ:OM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

27.7% of Avita Medical shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by insiders. Comparatively, 2.5% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Avita Medical has higher earnings, but lower revenue than Outset Medical. Avita Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	4.62	-$48.59M	-$1.44	N/A
Outset Medical	$119.48M	0.58	-$81.65M	-$4.09	N/A

Avita Medical has a net margin of -56.96% compared to Outset Medical's net margin of -63.06%. Avita Medical's return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
Outset Medical	-63.06%	-61.67%	-28.25%

Avita Medical has a beta of 2.02, suggesting that its stock price is 102% more volatile than the broader market. Comparatively, Outset Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Avita Medical currently has a consensus target price of $11.40, indicating a potential upside of 5.95%. Outset Medical has a consensus target price of $10.00, indicating a potential upside of 172.48%. Given Outset Medical's higher probable upside, analysts clearly believe Outset Medical is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Avita Medical and Avita Medical both had 1 articles in the media. Avita Medical's average media sentiment score of 1.00 beat Outset Medical's score of 0.76 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Outset Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Avita Medical beats Outset Medical on 10 of the 15 factors compared between the two stocks.

How does Outset Medical compare to CapsoVision?

Outset Medical (NASDAQ:OM) and CapsoVision (NASDAQ:CV) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

Outset Medical currently has a consensus price target of $10.00, indicating a potential upside of 172.48%. CapsoVision has a consensus price target of $9.50, indicating a potential upside of 60.20%. Given Outset Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Outset Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

CapsoVision has lower revenue, but higher earnings than Outset Medical. CapsoVision is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.58	-$81.65M	-$4.09	N/A
CapsoVision	$13.55M	21.90	-$25.32M	-$0.47	N/A

Outset Medical has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market. Comparatively, CapsoVision has a beta of -2.47, meaning that its stock price is 347% less volatile than the broader market.

Outset Medical has a net margin of -63.06% compared to CapsoVision's net margin of -214.74%. Outset Medical's return on equity of -61.67% beat CapsoVision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
CapsoVision	-214.74%	-177.85%	-135.07%

In the previous week, CapsoVision had 4 more articles in the media than Outset Medical. MarketBeat recorded 5 mentions for CapsoVision and 1 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.76 beat CapsoVision's score of 0.60 indicating that Outset Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CapsoVision	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Outset Medical beats CapsoVision on 10 of the 14 factors compared between the two stocks.

How does Outset Medical compare to Treace Medical Concepts?

Outset Medical (NASDAQ:OM) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, Outset Medical and Outset Medical both had 1 articles in the media. Treace Medical Concepts' average media sentiment score of 1.34 beat Outset Medical's score of 0.76 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Outset Medical has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

Outset Medical currently has a consensus price target of $10.00, suggesting a potential upside of 172.48%. Treace Medical Concepts has a consensus price target of $5.17, suggesting a potential upside of 10.00%. Given Outset Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Outset Medical is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Treace Medical Concepts has higher revenue and earnings than Outset Medical. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.58	-$81.65M	-$4.09	N/A
Treace Medical Concepts	$212.69M	1.44	-$59M	-$0.93	N/A

Treace Medical Concepts has a net margin of -28.99% compared to Outset Medical's net margin of -63.06%. Outset Medical's return on equity of -61.67% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

84.1% of Treace Medical Concepts shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Treace Medical Concepts beats Outset Medical on 8 of the 15 factors compared between the two stocks.

How does Outset Medical compare to Profound Medical?

Outset Medical (NASDAQ:OM) and Profound Medical (NASDAQ:PROF) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Profound Medical has lower revenue, but higher earnings than Outset Medical. Profound Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.58	-$81.65M	-$4.09	N/A
Profound Medical	$16.10M	15.47	-$42.57M	-$0.98	N/A

In the previous week, Profound Medical had 3 more articles in the media than Outset Medical. MarketBeat recorded 4 mentions for Profound Medical and 1 mentions for Outset Medical. Profound Medical's average media sentiment score of 0.83 beat Outset Medical's score of 0.76 indicating that Profound Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Profound Medical	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Outset Medical has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market.

Outset Medical currently has a consensus target price of $10.00, suggesting a potential upside of 172.48%. Profound Medical has a consensus target price of $11.50, suggesting a potential upside of 68.62%. Given Outset Medical's higher probable upside, equities research analysts plainly believe Outset Medical is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

47.9% of Profound Medical shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Outset Medical has a net margin of -63.06% compared to Profound Medical's net margin of -171.57%. Outset Medical's return on equity of -61.67% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
Profound Medical	-171.57%	-63.03%	-51.24%

Summary

Outset Medical beats Profound Medical on 9 of the 17 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OM vs. The Competition

Export

Metric	Outset Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$68.42M	$5.75B	$7.21B	$12.67B
Dividend Yield	N/A	1.75%	2.53%	8.56%
P/E Ratio	-0.90	25.86	272.66	25.23
Price / Sales	0.58	80.80	635.76	104.55
Price / Cash	N/A	33.05	76.98	52.08
Price / Book	0.72	6.08	12.83	6.10
Net Income	-$81.65M	$147.75M	$3.47B	$348.86M
7 Day Performance	-10.27%	-0.74%	-0.12%	-1.90%
1 Month Performance	-26.45%	3.77%	6.74%	1.96%
1 Year Performance	-73.35%	7.38%	25.09%	15.30%

Outset Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OM Outset Medical	2.7544 of 5 stars	$3.67 +0.8%	$10.00 +172.5%	-73.3%	$68.42M	$119.48M	N/A	520
TLSI TriSalus Life Sciences	1.2301 of 5 stars	$5.03 -1.6%	$7.50 +49.1%	-0.4%	$314.65M	$45.15M	N/A	106
RCEL Avita Medical	2.4838 of 5 stars	$10.50 +6.0%	$10.20 -2.9%	+150.8%	$305M	$71.61M	N/A	130	Positive News
CV CapsoVision	3.4014 of 5 stars	$5.85 +0.3%	$8.50 +45.3%	+62.5%	$291.77M	$13.55M	N/A	90	Analyst Upgrade
TMCI Treace Medical Concepts	3.1412 of 5 stars	$4.81 +10.1%	$5.17 +7.5%	-34.4%	$284.20M	$212.69M	N/A	250	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OM) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Outset Medical (OM) Competitors

OM vs. TLSI, RCEL, CV, TMCI, and PROF

How does Outset Medical compare to TriSalus Life Sciences?

Summary

How does Outset Medical compare to Avita Medical?

Summary

How does Outset Medical compare to CapsoVision?

Summary

How does Outset Medical compare to Treace Medical Concepts?

Summary

How does Outset Medical compare to Profound Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Outset Medical (OM) Competitors

OM vs. TLSI, RCEL, CV, TMCI, and PROF

How does Outset Medical compare to TriSalus Life Sciences?

Do institutionals & insiders have more ownership in OM or TLSI?

Is OM or TLSI more profitable?

Which has better earnings and valuation, OM or TLSI?

Does the media favor OM or TLSI?

Do analysts rate OM or TLSI?

Which has more volatility & risk, OM or TLSI?

Summary

How does Outset Medical compare to Avita Medical?

Do insiders and institutionals believe in RCEL or OM?

Which has higher valuation & earnings, RCEL or OM?

Is RCEL or OM more profitable?

Which has more volatility and risk, RCEL or OM?

Do analysts rate RCEL or OM?

Does the media refer more to RCEL or OM?

Summary

How does Outset Medical compare to CapsoVision?

Do analysts rate OM or CV?

Which has better earnings and valuation, OM or CV?

Which has more risk & volatility, OM or CV?

Is OM or CV more profitable?

Does the media prefer OM or CV?

Summary

How does Outset Medical compare to Treace Medical Concepts?

Does the media prefer OM or TMCI?

Which has more risk & volatility, OM or TMCI?

Do analysts prefer OM or TMCI?

Which has better valuation & earnings, OM or TMCI?

Is OM or TMCI more profitable?

Do institutionals and insiders hold more shares of OM or TMCI?

Summary

How does Outset Medical compare to Profound Medical?

Which has stronger earnings & valuation, OM or PROF?

Does the media prefer OM or PROF?

Which has more volatility & risk, OM or PROF?

Do analysts recommend OM or PROF?

Do insiders & institutionals hold more shares of OM or PROF?

Is OM or PROF more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools